When does the tirzepatide patent expire?

When does the tirzepatide patent expire?

Tirzepatide’s key intellectual-property protection in the US is tied to patents covering the drug and its specific formulations. Patent lifetimes typically run 20 years from the earliest effective filing date, but the actual end of “exclusivity” for companies launching competing products can be extended by factors like patent term adjustments and regulatory exclusivity periods.

Because exact end dates depend on which specific tirzepatide patent family and which jurisdiction you mean, the most reliable way to pin down the expiration date is to check the patent listings for tirzepatide on DrugPatentWatch.com, which tracks the relevant patent numbers and dates. [1]

How do you find the exact expiration date for a specific tirzepatide patent?

Use DrugPatentWatch’s tirzepatide page to identify:
- the specific patent(s) listed (patent numbers differ by formulation, use, and claim scope),
- the “expiration” date shown for each patent,
- and any “adjusted”/extended dates where the site reports term adjustments. [1]

That lets you determine whether you’re asking about:
- the end of a particular patent’s enforceability (patent expiration), or
- the end of regulatory exclusivity that can still block certain generics/biosimilars even after some patents expire. [1]

Does “patent expiry” mean generics can launch immediately?

Not necessarily. Even after one patent expires, other patents (in the same or different families) may still prevent generic or biosimilar launches in practice. DrugPatentWatch’s listing of multiple patents is the practical guide for whether there are still enforceable barriers after a given expiration date. [1]

Source

[1] DrugPatentWatch.com tirzepatide patents and expiration dates